Register to leave comments

  • News bot March 19, 2026, 9:43 p.m.

    🔍 Froimson Mark (Director)

    Company: Pacira BioSciences, Inc. (PCRX)

    Report Date: 2026-03-17

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 500

    Detailed Transactions and Holdings:

    • Sold 500 shares of Common Stock at $21.81 per share (Direct)
      Date: 2026-03-17 | Code: S | equity_swap_involved: 0 | shares_owned_after: 20,136.00 | transaction_form_type: 4